MYL Mylan, Inc. Stock DD Sunday, March 30, 2014 9:16:24 PM

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
MYL Mylan, Inc. $MYL Company Overview 

Stock Message Board http://investorshangout.com/search?q=MYL&...mp;yt1=Go!

Last Updated: Sunday, March 30, 2014 9:16:24 PM

Mylan, Inc. MYL Current Price and Quotes
Last Price 48.83
Previous Close 48.58 Open 48.75
Daily Range 50.36 - 48.41 52wk Range 57.52 - 27.66
Volume 3,944,749 Dividend N/A
Average Vol (3m) 4,499,993 Yield N/A
Mylan, Inc. MYL
Company Information

1500 Corporate Drive
Canonsburg, PA 15317

Website: http://www.mylan.com
Phone: (724) 514-1800

Mylan, Inc. MYL
Not Available

Mylan, Inc. MYL
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2013 10-K
CIK 0000069499
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: PA, USA
Year of Inc. Not Available
Employees Not Available
Company Notes

Formerly=Mylan Laboratories, Inc until 10-07
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Mylan, Inc. MYL
MYL Security Details

Share Structure

Market Value1 $19,573,755,243 a/o Mar 28, 2014
Shares Outstanding 371,912,507 a/o Feb 21, 2014
Float Not Available
Authorized Shares Not Available
Par Value  0.4
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Sep 26, 2001 Sep 28, 2001 Oct 15, 2001
Security Notes

Capital Change=shs increased by 3 for 2 split. Rec date=07-31-95. Pay date=08-15-95
New Issue=2-73 227,797 shs at $10.50 by Moore, Leonard & Lynch, Inc. et al.
Div. One Pfd Stk Purchase Right for each sh Com held. Effective date=9-5-96. Expiration date=9-5-2006
Capital Change=shs increased by 3 for 2 split. Ex-date=01/28/2003. Rec date=01/17/2003. Pay date=01/27/2003.
Short Selling Data

Short Interest 33,779,563 (-61.26%)
Nov 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

Mylan, Inc. MYL Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6,909,143 6,796,110 6,129,825 5,450,522
Cost of Revenue 3,868,800 3,887,806 3,566,461 3,233,125
Gross Profit 3,040,343 2,908,304 2,563,364 2,217,397
Operating Expenses

Research and Development 507,823 401,341 294,728 282,146
Sales, General and Admin. 1,411,629 1,400,747 1,214,631 1,086,609
Non-Recurring Items (14,639) (3,133) 48,556 127,058
Other - - - -
Operating Income 1,135,530 1,109,349 1,005,449 721,584
Income From Continuing Operations

Add'l Income/Expense Items (74,854) 3,429 (14,869) (34,178)
Earnings Before Interest and Tax 1,060,676 1,112,778 990,580 687,406
Interest Expense 313,336 308,699 335,944 331,462
Earnings Before Tax 747,340 804,079 654,636 355,944
Income Tax 120,808 161,145 115,833 10,402
Minority Interest 2,821 2,084 1,993 427
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 623,711 640,850 536,810 345,115
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 623,711 640,850 536,810 345,115
Preferred Stock and Other Adjustments - - - (121,535)
Net Income Applicable to Common Shareholders 623,711 640,850 536,810 223,580

Mylan, Inc. MYL Recent News

Mar 27, 2014 Mylan Wins Breach of Contract Case against GlaxoSmithKline
Mar 24, 2014 District Court Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution
Mar 24, 2014 New Product Offerings, Development and Research Collaboration, Upcoming Investor Conference, and Board Election - Analyst Notes on CVS Caremark, Teva, Zoetis, McKesson, and Mylan
Mar 21, 2014 Pharmaceutical Equities under Review -- Research on Zoetis, Mylan, AVANIR Pharma and Actavis
Mar 13, 2014 Mylan Comments on Favorable Ruling in Generic Celebrex® Patent Suit
Mar 11, 2014 Mylan Launches Naloxone Hydrochloride Injection
Mar 11, 2014 Mylan Introduces Critical Care Segment in India
Mar 11, 2014 Mylan Nominates JoEllen Lyons Dillon for Election to Board of Directors
Mar 1, 2014 Mylan Specialty to Present Poster Presentations about an Individual's Risk of Anaphylaxis at Upcoming Medical Meeting
Feb 28, 2014 Critical Alerts For Amazon, Delta Airlines, Mylan Laboratories, Rackspace Hosting, and Sanofi Aventis Released By InvestorsObserver

1
2
3
next >

MYL Mylan, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=MYL&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/MYL/quote
Stock Chart http://www.otcmarkets.com/stock/MYL/chart
Company Info http://www.otcmarkets.com/stock/MYL/company-info
Recent News http://www.otcmarkets.com/stock/MYL/news
Financials http://www.otcmarkets.com/stock/MYL/financials
Filings and Disclosure http://www.otcmarkets.com/stock/MYL/filings
Short Sales http://www.otcmarkets.com/stock/MYL/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/MYL/insider-transactions
Research Reports http://www.otcmarkets.com/stock/MYL/research
Summary http://finance.yahoo.com/q?s=MYL
Historical Prices http://finance.yahoo.com/q/hp?s=MYL+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=MYL
Basic Chart http://finance.yahoo.com/q/bc?s=MYL+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MYL+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=MYL+Headlines
Press Releases http://finance.yahoo.com/q/p?s=MYL+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=MYL+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=MYL+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=MYL+Industry
Major Holders http://finance.yahoo.com/q/mh?s=MYL+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=MYL+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=MYL+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=MYL
Balance Sheet http://finance.yahoo.com/q/bs?s=MYL
Cash Flow http://finance.yahoo.com/q/cf?s=MYL+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/MYL
Market Watch http://www.marketwatch.com/investing/stock/MYL
Bloomberg http://www.bloomberg.com/quote/MYL:US
Morningstar http://quotes.morningstar.com/stock/s?t=MYL
Bussinessweek http://investing.businessweek.com/research/st...ticker=MYL
Barchart http://www.barchart.com/quotes/stocks/MYL
OTC Short Report http://otcshortreport.com/index.php?index=MYL
Investopedia http://www.investopedia.com/markets/stocks/MYL/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Essity's Recent Share Buyback: What You Need to Know

Updated Category News Views 154

Essity's Commitment to Share Buybacks In recent developments, Essity Aktiebolag (publ) has embarked on a strategic journey involving the repurchase of Class B shares. From November 4 to November 8, 2024, the company successfully bought back a total of 270,000 of its own Class B shares. This initiative is part of a broader buyback program that aims to enhance shareholder...

Continue Reading
Michael Kalen Steers Eagle Rock Wealth for Big Growth

Updated Category News Views 6

Michael Kalen Takes Charge at Eagle Rock Wealth Now, here's a development that should make investors sit up and take notice: Michael Kalen has been named President of Eagle Rock Wealth, one of the big shots in private wealth management. With a history mired in leadership across major financial sectors, Kalen isn't your run-of-the-mill executive. His past gigs as President...

Continue Reading
Veris Residential's $3.4B Acquisition: Cashing In Big Time

Updated Category News Views 195

Veris Residential Seals the Deal A big shake-up in the multifamily REIT market—Veris Residential (NYSE:VRE) just got the green light for a whopping acquisition by Affinius Capital and pals, all to the tune of $3.4 billion in cash. Yep, you heard that right. Shareholders are looking at a sweet $19.00 per share coming their way. That's a hefty 23.2% premium over the...

Continue Reading
Kairon Labs and Solidus Labs Join Forces for Market Integrity

Updated Category News Views 281

Kairon Labs Partners with Solidus Labs to Innovate Market Practices Kairon Labs, a leading crypto market maker and liquidity provider, has entered into a strategic partnership with Solidus Labs, a pioneer in crypto-native compliance and risk management solutions. This collaboration is focused on enhancing Kairon Labs' compliance program in anticipation of the European...

Continue Reading
Investors Facing Class Action Lawsuits: Indivior, CrowdStrike, DXC, Five Below

Updated Category News Views 194

Update on Class Action Lawsuits Involving Major Stocks Investors, especially those holding shares in important companies, are currently facing a series of class action lawsuits. Renowned law firm Bragar Eagel & Squire, P.C. has announced the initiation of class actions against Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company...

Continue Reading